RE:RE:The dynamics of the $3.2 Billion acquisition of Translate x Interesting comparison.
Translate's 5 year chart is quite different from ONC's.
I had a look at the last 23 years of ONC's clinical trials: https://tinyurl.com/4rwcyczf
Not much to write home about, except for their "Carcinoma, Squamous Cell of Head and Neck" trial. This trial was very interesting/compelling. It made it to phase 3, in May of 2014 (end date). That's their only trial to make it into phase 3. That means efficacy and safety were there. Anyone know why it stalled out?
I see they intend to register for a phase 3 study after their encouraging phase 2 Aware-1 trial, but nothing concrete date-wise, yet. Anyone know the scoop on this? Thanks.
By the way, is there a difference betwen paleorep and reolysin? Looks like the same thing. Not sure why the rebrand / different name. Aren't they all the same reovirus?